News
TOIIW
0.0651
0.00%
0.0000
CORRECTED-BRIEF-(OFFICIAL)-Oncology Institute Q4 revenue USD 71 million (Mar.9)
Reuters · 03/17 10:29
BRIEF-Oncology Institute Rebrands Clinical Trials Division
Reuters · 12/15/2022 13:18
BRIEF-The Oncology Institute Reports Third Quarter 2022 Financial Results
Reuters · 11/09/2022 21:44
The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call
CERRITOS, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter results after the mar...
GlobeNewswire · 10/19/2022 12:00
The Oncology Institute Executives to Speak at Key Industry Conferences in Q4
Publicly traded company leaders will share perspectives on the future of value-based oncology careCERRITOS, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc (NASDAQ: TOI), one of the largest value-based oncology groups in the United St...
GlobeNewswire · 10/17/2022 20:05
The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials
Phil Reger and Cristina Green Will Serve as the Chief Information Officer and Vice President of Clinical Research, RespectivelyCERRITOS, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based on...
GlobeNewswire · 10/11/2022 12:00
BRIEF-The Oncology Institute Appoints Two New Board Members
BRIEF-The Oncology Institute Appoints Two New Board Members
Reuters · 09/22/2022 20:12
The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium
CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, will participate on the “Ne...
GlobeNewswire · 09/15/2022 12:00
The Oncology Institute to Participate at the Baird Newly Public Company Virtual Access Day
CERRITOS, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, and its Chief Fina...
GlobeNewswire · 08/16/2022 12:00
The Oncology Institute Continues its Nevada Expansion
Las Vegas-based practice of Dr. Nutan Parikh to join TOICERRITOS, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced the acquisition...
GlobeNewswire · 07/26/2022 12:00
The Oncology Institute Announces Second Quarter 2022 Earnings Release Date and Conference Call
CERRITOS, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) today announced that the company will release its second quarter results after the market close on Tuesday August 9, 2022, to be followed by a conference ...
GlobeNewswire · 07/19/2022 12:00
The Oncology Institute Continues Southern California Expansion
Orange County-based practice of Dr. Ranjan Sapra to combine with TOI.CERRITOS, Calif., July 07, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced to...
GlobeNewswire · 07/07/2022 20:05
The Oncology Institute Announces Expanded Strategic Agreement with McKesson for Distribution of Pharmaceuticals
CERRITOS, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups in the United States, announced today the signing of an expanded partnership agreement w...
GlobeNewswire · 06/27/2022 12:00
BRIEF-The Oncology Institute Set To Join The Russell 2000 And Russell 3000 Indexes
reuters.com · 06/07/2022 21:53
The Oncology Institute set to join the Russell 2000® and Russell 3000® Indexes
CERRITOS, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that it will join the Russell 2000Ò and Russell 3000Ò Indexes after the 202...
GlobeNewswire · 06/07/2022 20:05
The Oncology Institute Announces Opening of Austin’s Newest Innovative Cancer Clinics
The company is making world-class, community-based cancer care more accessible to Texas residentsAUSTIN, Texas, June 02, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United State...
GlobeNewswire · 06/02/2022 20:05
LAB, EAR and CHRA among mid-day movers
Gainers: Redbox Entertainment (RDBX) +37%. Vivid Seats (SEAT) +37%. VIQ Solutions (VQS) +29%. Modine Manufacturing (MOD) +28%. Eargo (EAR) +27%. Charah Solutions (CHRA) +23%. Baozun (BZUN) +21%. Alpha Teknova (TKNO)
Seekingalpha · 05/26/2022 16:26
The Oncology Institute to Participate at Upcoming Investor Conferences
CERRITOS, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Brad Hively, Chief Executive Officer, will participate at the following...
GlobeNewswire · 05/17/2022 20:05
BRIEF-Oncology Institute- On May 11, 2022, Board Of Co Approved Share Repurchase Program With Authorization To Purchase Up To $20 Million Of Co’S Common Stock
reuters.com · 05/12/2022 10:23
Investors in Oncology Institute (NASDAQ:TOI) from a year ago are still down 12%, even after 12% gain this past week
It is doubtless a positive to see that the The Oncology Institute, Inc. ( NASDAQ:TOI ) share price has gained some 30...
Simply Wall St. · 05/09/2022 13:59
More
Webull provides a variety of real-time TOIIW stock news. You can receive the latest news about The Oncology Institute Inc through multiple platforms. This information may help you make smarter investment decisions.
About TOIIW
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices that serve patients at approximately 67 clinic locations across 11 markets and four states throughout the United States. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, and dispensary, clinical trial services, radiation, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. It offers cutting-edge treatment through clinical trials. It also offers convenient, safe appointments via telehealth. The Company through Innovative Clinical Research Institute, LLC (ICRI), provides and manages clinical trial services and research for the benefit of cancer patients. The Company's segment includes patient care, dispensary, and clinical trials & other. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.